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Abstract In the pineal gland, the membrane guanylate cyclase
activity was specifically stimulated by K2D=A-adrenergic receptor
(K2D=A-AR) agonists. The agonists, however, did not stimulate
the cyclase activity in the cell-free membranes. It was possible to
stimulate the cyclase in cell-free membranes by the addition of
the pineal soluble fraction, but this stimulation was Ca2+-
dependent and K2D=A-agonist-independent. It was also possible
to achieve Ca2+-dependent stimulation of the cyclase by the
direct addition of CD-GCAP to the isolated pineal membranes.
CD-GCAP is a Ca2+-binding protein and is a specific activator
of one of the two members of the ROS-GC subfamily of
membrane guanylate cyclases, ROS-GC1. The soluble fraction
of the pineal gland stimulated recombinant ROS-GC1 in a Ca2+-
dependent fashion. The direct presence of both ROS-GC1 and
CD-GCAP in the pineal was established by molecular cloning/
PCR studies. The findings demonstrate the existence of a novel
signal transduction mechanism ^ the linkage of the K2D=A-AR
signaling system with ROS-GC1 transduction system, occurring
through intracellular Ca2+ via CD-GCAP.
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1. Introduction
The original investigations in the late 1970s demonstrated
the presence of an epinephrine-dependent membrane guanyl-
ate cyclase in rat carcinoma cells and showed that the cyclase
activation occurs via the K-adrenergic receptor (K-AR), there-
by establishing the existence of an K-AR-coupled membrane
guanylate cyclase transduction system in these cells [1,2]. At
the time, neither the heterogeneity of K-AR nor that of gua-
nylate cyclase was de¢ned. Hence, the biochemical and mo-
lecular nature of the interactions between the signaling recep-
tor and the transduction component of the cyclase remained
elusive. The rat receptor was then puri¢ed and biochemically
characterized [3], cloned [4,5], and shown to belong to a new
pharmacologically de¢ned K2D-AR subtype [5,6]. This implies
that the original carcinoma receptor subtype linked to the
membrane guanylate cyclase was K2D-AR. It has now been
established that the K2D-AR subtype is a species variant of
the pharmacologically distinct K2A-AR [6,7] and, therefore, is
now referred to as K2D=A-AR [8].
The present study shows the presence of a membrane gua-
nylate cyclase in the pineal gland that is also linked to the
K2D=A-AR signaling: (1) the stimulation of the cyclase is spe-
ci¢cally mediated by K2D=A-AR and involves Ca2 ; (2) the
signaling is indirect ; (3) the stimulation of the cyclase can
be independently mimicked by the pineal soluble fraction in
a Ca2-dependent fashion; and (4) the reconstitution and mo-
lecular cloning/PCR studies indicate that the cyclase is ROS-
GC1 and that its activator is CD-GCAP. Recent studies have
shown that the CD-GCAP/ROS-GC1 transduction system is
speci¢cally regulated by intracellular Ca2, and may be linked
to the retinal synaptic activity (reviewed in [9]). This report,
therefore, demonstrates a new catecholamine signaling mech-
anism in the pineal gland, that includes components which
mimic the retinal CD-GCAP/ROS-GC1 transduction system.
2. Materials and methods
2.1. Treatment of pineal glands and isolation of membranes
Bovine pineal glands were obtained fresh from a slaughterhouse
(Moyer Packaging Co., Souderton, PA), washed in bu¡er A [0.32
M sucrose, 20 mM Tris-HCl (pH 7.5), 0.5 mM dithiothreitol
(DTT), 0.5 mM ethylene diamine tetraacetate (EDTA), and protease
inhibitors: 1 mM benzamidine and 0.5 mM phenylmethylsulfonyl
£uoride (PMSF)] and minced carefully in the same bu¡er. The pineal
pieces were divided into portions of equal weights for incubation in
Dulbecco’s modi¢ed Eagle’s medium in 6-well dishes at 37‡C in at-
mosphere containing 5% CO2 with or without added reagents. After
15 min of incubation, the tissue was washed twice in bu¡er A and
homogenized with a Te£on pestle. The homogenates were initially
centrifuged at 10 000Ug, followed by centrifugation at 100 000Ug.
The pellet constituted the membrane fraction and the supernatant
was labeled as the ‘soluble fraction’. The soluble fraction was incu-
bated at 75‡C for 3 min in the presence of 5 mM CaCl2 (heat inacti-
vation) and centrifuged at 10 000Ug. The supernatant was dialyzed
against bu¡er containing 25 mM Tris-HCl (pH 7.5), 5 mM MgCl2,
1 mM CaCl2 and protease inhibitors benzamidine (1 mM) and PMSF
(0.5 mM).
2.2. Expression of membrane guanylate cyclases in COS cells
COS7 cells maintained in Dulbecco’s modi¢ed Eagle’s medium with
penicillin, streptomycin, and 10% fetal bovine serum, were transfected
according to previously described protocols with the atrial natriuretic
factor-receptor guanylate cyclase (ANF-RGC) [10], C-type natriuretic
factor-receptor guanylate cyclase (CNP-RGC) [11], or ROS-GC1 [12]
expression constructs. At 60 h after transfection, cells were washed
with bu¡er containing 50 mM Tris-HCl (pH 7.5) and 10 mM MgCl2,
scraped into 2 ml of cold bu¡er, homogenized, centrifuged for 15 min
at 5000Ug, and washed several times with the same bu¡er. The pellet
represented the crude membranes.
2.3. Guanylate cyclase assay
Membranes isolated from the pineal gland or COS7 cells trans-
fected as above were assayed for guanylate cyclase activity [13]. All
experiments were carried out in triplicate and repeated at least three
times for reproducibility. The results are expressed as mean þ standard
deviation.
2.4. Isolation of RNA and reverse transcriptase-polymerase chain
reaction
RNA was isolated from the pineal gland through acid-phenol ex-
traction procedure [14] and reverse transcriptase reaction was carried
out as described earlier [15]. Brie£y, 10 Wg of RNA was treated with
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RNase-free DNase (Promega Corp) and converted into cDNA with
Superscript II reverse transcriptase (Life Technology). A 200 bp frag-
ment corresponding to the CD-GCAP/S100B mRNA was ampli¢ed as
described previously [16] using primers 5P-GTTGCCCTCATT-
GAYGTNTTYCA-3P (corresponding to nt 145^157 of bovine CD-
GCAP) and 5P-ATAAACTCCTGGAARTCRAYTC-3P (complemen-
tary to nt 322^344). Ampli¢cation of ROS-GC1 (548 bp fragment)
and L30 (238 bp fragment) for quantitative RT-PCR was exactly as
described in [17]. The identity of each ampli¢ed fragment was con-
¢rmed by sequencing using the fmol sequencing method (Promega).
The ampli¢ed products were electrophoresed, transferred to nytran
membranes and hybridized to radioactively labeled probes generated
from the respective cDNA clones. The blots were washed to remove
non-speci¢c hybridization and subjected to autoradiography. The sig-
nals were quanti¢ed using the Imagemaster VDS system (Pharmacia).
2.5. Cloning of ROS-GC1 from bovine pineal gland
A pineal cDNA library was constructed exactly as described in [12]
for retinal cDNA library. The library was screened with multiple
probes derived from the retinal ROS-GC1 cDNA which were radio-
actively labeled and used for hybridization as described in [12]. A
single positive clone was isolated and sequenced to determine its iden-
tity.
3. Results and discussion
3.1. The K2D=A-AR-mediated signal activates membrane
guanylate cyclase
A general characteristic of all members of K2-AR and L-AR
families is that epinephrine is their natural ligand (reviewed in
[18,19]). The members of these two families, however, are
linked in opposing fashions to its transducer adenylate cy-
clase: the K2-AR signaling inactivates and the L-AR signaling
activates the adenylate cyclase [18,19]. Early studies with the
rat adrenocortical carcinoma cells showed that the epineph-
rine signal mediated by the K2D=A-AR not only inhibits ade-
nylate cyclase activity, but also stimulates the membrane gua-
nylate cyclase activity in an indirect fashion (reviewed in [20]).
To determine if an epinephrine-responsive membrane guanyl-
ate cyclase existed in the pineal gland, the glands were treated
with the incremental concentrations of epinephrine, and the
membrane fractions were scrutinized for the guanylate cyclase
activity. Epinephrine caused a concentration-dependent in-
crease in the membrane guanylate cyclase activity (Fig. 1A).
The concentration causing half-maximal response (EC50) was
80 nM. The enzyme saturation was achieved at 1 WM with
more than three-fold stimulation and signi¢cant stimulation
was observed with as little as 1 nM of epinephrine (Fig. 1A).
Rauwolscine, an K2-AR antagonist [8], caused a near-total
loss of the epinephrine-dependent cyclase stimulation (Fig.
1B). Thus, the pineal gland contains a membrane guanylate
cyclase that is epinephrine-dependent and epinephrine acts
through K2-AR.
Among the K2-ARs, the bovine pineal gland is exclusively
populated by the K2D=A-AR subtype as demonstrated by ex-
tensive pharmacological analyses [21] suggesting the function-
al linkage of this receptor subtype with the membrane gua-
nylate cyclase. To determine if this was indeed the case, the
e¡ect of speci¢c K2D=A-AR agonists and antagonists on this
linkage was investigated. The membrane guanylate cyclase
activity of the pineal gland was measured after its treatment
with p-aminoclonidine (PAC), a speci¢c agonist. PAC yielded
a stimulatory pattern similar to that of epinephrine, with an
EC50 of 95 nM and the maximal enzyme saturation was
achieved at 1WM PAC (Fig. 1A). The cyclase stimulation
was completely blocked by two speci¢c K2D=A-AR antagonists,
rauwolscine and yohimbine, but not by the K1-AR antagonist,
prazosin (Fig. 1B). Similarly, UK14304, another speci¢c
K2D=A-AR agonist, elicited a dose-dependent stimulation of
membrane guanylate activity (Fig. 1A) with EC50 value iden-
tical to PAC and again the stimulation was blocked by the
antagonist, yohimbine (Fig. 1B). Thus, the epinephrine e¡ect
was mimicked by K2D=A-AR agonists and the e¡ect could be
blocked by speci¢c K2D=A-AR antagonists but not the K1-AR
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Fig. 1. Epinephrine activation of pineal guanylate cyclase through K2D=A-AR. Treatment of pineal glands, isolation of membranes and guanyl-
ate cyclase assay was performed as described in Section 2. A: Epinephrine and K2D=A-AR agonists stimulate pineal guanylate cyclase indirectly.
Pineal glands were treated with indicated concentrations of epinephrine (EPI) or K2D=A-AR agonists (p-aminoclonidine (PAC) or UK 14304
(UK)) as described in Section 2. Membranes were then isolated and assayed for guanylate cyclase activity (solid line). The e¡ect of PAC addi-
tion on isolated membranes (dotted line) was also investigated. Values presented are mean þ standard deviation. B: Pineal membrane guanylate
cyclase is stimulated upon K2D=A-AR activation speci¢cally. All agents used for treatment were at a concentration of 1 WM and the treatment
was for 15 min at 37‡C. Experiments were carried out in triplicate and repeated thrice for reproducibility. Values presented are mean þ standard
deviation. EPI, epinephrine; PAC, p-aminoclonidine; PRA, prazosin; RAU, rauwolscine; UK, UK 14304; YOH, yohimbine.
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antagonist. Hence, activation of the K2D=A-AR subtype signals
the stimulation of pineal membrane guanylate cyclase and
there is no involvement of any other K2-AR subtype or K1-
AR.
3.2. The K2D=A-AR-mediated membrane guanylate cyclase
signaling occurs indirectly and involves calcium
To determine if the K2D=A-AR-mediated cyclase signaling
was direct or indirect, membranes isolated from untreated
pineal gland were tested directly for the PAC-dependent gua-
nylate cyclase activity. PAC up to 1 WM concentration, in
contrast to results obtained with intact gland, did not stimu-
late the guanylate cyclase activity (Fig. 1A). Thus, the K2D=A-
AR signaling of the membrane guanylate cyclase is indirect.
At present, two types of membrane guanylate cyclases have
been characterized (reviewed in [9,22]). One type constitutes a
group of peptide receptors and is directly activated by the
peptide hormones. The other type distinguishes itself from
the peptide receptors in that its members are not regulated
by extracellular peptides. This group consists of two members
of the ROS-GC subfamily, ROS-GC1 and ROS-GC2, which
are modulated by intracellular Ca2 signals. This suggested a
possible mechanism of the K2D=A-AR signaling in which acti-
vation of the receptor causes a rise in intracellular Ca2,
which activates the pineal ROS-GC via CD-GCAP.
With this hypothesis, experiments were conducted to deter-
mine the possible role of calcium in mediating the K2D=A-AR
signaling in the pineal gland. Three di¡erent agents which
a¡ect intracellular Ca2 in di¡erent ways were used:
A23187, a Ca2 ionophore; thapsigargin, which mobilizes in-
tracellular Ca2 [23] ; and nifedipine, a Ca2-channel blocker
[24]. The results presented in Fig. 2 demonstrate that: (1)
PAC-dependent stimulation of the membrane guanylate cy-
clase is blocked by nifedipine, which has no e¡ect by itself ;
(2) treatment of the pineal gland with A23187 and thapsigar-
gin causes a stimulation of the membrane guanylate cyclase
activity, which mimics the cyclase stimulation by PAC; (3)
concomitant addition of PAC does not cause signi¢cant
added stimulation of the membrane guanylate cyclase. Taken
together, these results demonstrate the role of intracellular
Ca2 in stimulating the pineal membrane guanylate cyclase
activity and suggest that the K2D=A-AR stimulates guanylate
cyclase through a rise in intracellular Ca2, possibly through
increased in£ux. This suggestion is consistent with the studies
in other reports, where activation of K2D=A-AR resulted in
stimulation of Gi, which in turn, opened the Ca2 channels,
causing a rise in intracellular Ca2 [25,26].
3.3. A heat-stable soluble factor in the pineal gland
directly stimulates the membrane guanylate cyclase in a
Ca2+-dependent manner
Clued by the observation that the K2D=A-AR stimulation of
the pineal gland membrane guanylate cyclase is mediated by
calcium and with the knowledge that, speci¢cally, ROS-GC1
is intracellularly regulated by Ca2 through a heat-stable
Ca2-binding protein CD-GCAP [16,27], the possibility was
considered that the pineal gland cyclase might be regulated by
Ca2 through CD-GCAP or a CD-GCAP-like protein. To
test this possibility, the soluble fraction of the pineal gland
was heat-inactivated and the guanylate cyclase activity in the
isolated membranes of pineal glands was measured in the
presence and absence of 1 mM Ca2. The results indicated
that the soluble factor stimulated the membrane guanylate
cyclase activity more than three fold, but this e¡ect was lost
if EGTA (a known Ca2 chelator) was added (Fig. 3). Thus,
the pineal gland membrane guanylate cyclase is stimulated by
a pineal soluble factor, which behaves like CD-GCAP.
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Fig. 2. K2D=A-AR guanylate cyclase signaling involves calcium.
Treatment of pineal glands, isolation of membranes and guanylate
cyclase assay was performed as described in Section 2. All agents
used for treatment were at a concentration of 1 WM. Experiments
were carried out in triplicate and repeated thrice for reproducibility.
Values presented are mean þ standard deviation.
Fig. 3. Pineal soluble fraction stimulates ROS-GC1 in a Ca2-de-
pendent fashion. Pineal membranes or membranes from COS cells
expressing ANF-RGC, CNP-RGC, or ROS-GC1 were isolated as
described in Section 2. ANF-RGC, CNP-RGC, and ROS-GC1 de-
note membranes from COS cells transfected with constructs encod-
ing the respective cyclase. The membranes were incubated with 20
Wg of protein equivalents of pineal soluble fraction (SF) and assayed
for guanylate cyclase activity. ANF-RGC and CNP-RGC were also
incubated with ANF and CNP (0.1 WM) respectively in the presence
of 0.8 mM ATP. Experiments were carried out in triplicate and re-
peated thrice for reproducibility. Values presented are mean þ stand-
ard deviation.
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3.4. The heat-stable soluble factor mimics CD-GCAP in
the Ca2+-dependent stimulation of recombinant ROS-GC1,
and CD-GCAP stimulates the pineal gland membrane
guanylate cyclase activity in a Ca2-dependent manner
Biochemical and molecular analyses have established that
CD-GCAP is S100B (L,L), a member of the S100 proteins
family [28]. A unique functional feature of CD-GCAP is
that it is a positive regulator of ROS-GC1 when bound to
Ca2 [16,27]. Since CD-GCAP speci¢cally activates ROS-
GC1 [27,28], the possible presence of ROS-GC1 in the pineal
membranes was investigated by the addition of CD-GCAP
followed by assay for guanylate cyclase activity. Fig. 4A
shows that in the presence of 1 mM Ca2, CD-GCAP stim-
ulates the pineal gland membrane guanylate cyclase activity in
a dose-dependent fashion with a half-maximal activation at
V2 WM and saturation at V5 WM. In the absence of Ca2,
CD-GCAP had no e¡ect on the cyclase activity. This pattern
of the pineal cyclase stimulation is very similar to that estab-
lished earlier for the recombinant ROS-GC1 which is stimu-
lated by CD-GCAP with an EC50 of 1.1 WM and saturation at
V5 WM [16], thus indicating the presence of ROS-GC1 in the
pineal membranes.
The e¡ect of the pineal soluble fraction on the recombinant
ROS-GC1 activity was also tested. Membranes were isolated
from COS cells expressing ROS-GC1, and were incubated
with the pineal soluble fraction at a ¢xed (1 mM) Ca2 con-
centration. The pineal soluble fraction stimulated recombi-
nant ROS-GC1 more than 10-fold above its basal level in
the presence of 1 mM Ca2 ; addition of EGTA resulted in
loss of cyclase stimulation (Fig. 3).
Since the presence of two additional membrane guanylate
cyclases, ANF-RGC and CNP-RGC, has been reported in the
pineal gland [29], the e¡ect of pineal soluble fraction on these
cyclases expressed in COS cells, was investigated and was
found to be insigni¢cant (Fig. 3), consistent with the fact
that ANF-RGC and CNP-RGC are not regulated by intra-
cellular Ca2 [9]. However, the ligands ^ ANF and CNP ^
elicited a stimulatory response from the respective receptors,
ANF-RGC and CNP-RGC, indicating the ¢delity of expres-
sion of these receptors (Fig. 3). Thus, the stimulation was
speci¢c for ROS-GC1, which is characterized by Ca2-de-
pendent regulation [16,27,28], and establishes that the pineal
soluble fraction contains a factor that is functionally similar
to CD-GCAP.
At present, only three proteins ^ GCAP1, GCAP2 and CD-
GCAP [9] ^ are known to regulate ROS-GC1, while other
calcium-binding proteins such as calmodulin and troponin C
have no e¡ect on its activity [16]. Among GCAP1, GCAP2
and CD-GCAP, only CD-GCAP stimulates ROS-GC1 activ-
ity in response to high Ca2 and is heat stable [16,27,28] ^
features shared by the pineal soluble factor. The remote pos-
sibility that additional heat-sensitive proteins are present in
the pineal gland that may regulate ROS-GC1 in response to
elevated Ca2 levels, like CD-GCAP, cannot be ruled out.
3.5. Molecular probes directly demonstrate the presence of
CD-GCAP and ROS-GC1 in the pineal gland
Guided by the earlier observations that ROS-GC1 exclu-
sively resides (among the tissues tested) in the retina [12],
where CD-GCAP is also present and is a speci¢c regulator
of ROS-GC1 [16,27,28], and the present ¢ndings that the
pineal soluble factor stimulates the recombinant ROS-GC1
and also the native guanylate cyclase present in the pineal
membranes (Fig. 3), the direct molecular presence and the
relative abundance of ROS-GC1 and CD-GCAP in the pineal
gland was scrutinized. Results from quantitative RT-PCR
analyses presented in Fig. 4B show that both ROS-GC1 and
CD-GCAP are expressed in this tissue and at levels 2^3 times
lower when compared to the retina. The expression of L30,
measured as a control, remained the same between the two
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Fig. 4. A: CD-GCAP activation of pineal membrane guanylate cy-
clase. Isolation of membranes from pineal glands was carried out as
described in Section 2. Assay for guanylate cyclase activity was per-
formed in the absence of Ca2 (3Ca2) or in the presence of 1 mM
Ca2 (+Ca2). Values presented are mean þ standard deviation. B:
Relative abundance of ROS-GC1 vs. CD-GCAP in the retina and
the pineal gland. Quantitative RT-PCR was performed as described
in Section 2. Fragments corresponding to ROS-GC1, CD-GCAP
and L30 (30 kDa protein from the large subunit of the ribosome)
were ampli¢ed from equal amounts of RNA isolated from the reti-
na and the pineal gland. After electrophoresis, the products were
transferred onto nytran membranes and hybridized to probes gener-
ated from the respective cDNA clones. The blots were washed, ex-
posed and subjected to autoradiography. The signals were quanti¢ed
using Imagemaster VDS (Pharmacia).
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tissues indicating that equivalent amounts of cDNA were used
for the analyses. The results indicate that the relative amounts
of ROS-GC1 and CD-GCAP remains the same in the retina
and the pineal gland. To further establish the identity of CD-
GCAP and ROS-GC1 in the pineal gland at the molecular
level, a cDNA library from the pineal gland was screened for
the presence of ROS-GC1 and a single positive clone was
obtained and sequenced; the ampli¢ed fragments of CD-
GCAP mRNA was also sequenced. The ampli¢ed fragment
of CD-GCAP was identical to the region between nt 145 and
344 of bovine CD-GCAP sequence [16,27]. Sequencing of the
isolated ROS-GC1 cDNA clone revealed that it contained
regions corresponding to the catalytic domain and over 3 kb
of the 3P non-coding region with the sequence identical to the
ROS-GC1 cDNA cloned earlier from the bovine retina [12].
The presence of the second member of ROS-GC subfamily,
ROS-GC2, was not detected through RT-PCR in the pineal
gland [30]. Thus both biochemical and molecular analyses
indicate that the high Ca2 signal transduction pathway is
operational in the pineal gland.
3.6. Concluding remarks
By the molecular, biochemical and functional criteria, the
identity of the transduction components of the K2D=A-AR
linked guanylate cyclase signaling system have been revealed.
Epinephrine signal originates at the extracellular receptor por-
tion of the K2D=A-AR subtype and the signal transduction
occurs within the interior of the cell, resulting in the stimula-
tion of ROS-GC1.
It is noteworthy that a series of careful investigations have
demonstrated another linkage of epinephrine signaling with
the elevation of cellular cGMP [31,32], which occurs through
a mechanism di¡erent from the one reported in the present
study. This linkage [31,32] (i) is through conjoint activation of
K1- and L-AR, while activation of the individual receptor has
no e¡ect; and (ii) results in the activation of a soluble guanyl-
ate cyclase, whose identity is unknown. Thus, epinephrine, in
the pineal gland, signals the formation of cGMP via two dis-
tinct pathways: one pathway activates the soluble guanylate
cyclase, and the other, activates ROS-GC1 ^ a membrane
guanylate cyclase.
A model is envisioned for the K2D=A-AR guanylate cyclase
signaling where (i) the signaling system is turned on by the
binding of epinephrine to its K2D=A-AR, (ii) this causes a rise
of intracellular Ca2, (iii) Ca2 then binds to CD-GCAP, and
(iv) CD-GCAP activates the catalytic domain of ROS-GC1,
enhancing the production of cGMP. Thus, Ca2 couples the
7-transmembrane K2D=A-AR signaling system with the single
transmembrane ROS-GC1 transduction system. Prior to this
study, the CD-GCAP-ROS-GC1 interaction had been consid-
ered the exclusive domain of the retina. The ¢ndings of the
present report extend the boundary of the system and suggest
that the K2D=A-AR linked ROS-GC1 signal transduction sys-
tem might represent a uni¢ed feature of neurosensory cells.
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